Deutsche Bank
CGEM icon

Deutsche Bank’s Cullinan Oncology CGEM Stock Holding History

Deutsche Bank’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.97M Buy
382,840
+14,934
+4% +$222K ﹤0.01% 1198
2026
Q1 		$5.23M Sell
367,906
-218,730
-37% -$2.81M ﹤0.01% 1276
2025
Q4 		$6.07M Buy
586,636
+14,898
+3% +$134K ﹤0.01% 1229
2025
Q3 		$3.39M Buy
571,738
+4,957
+0.9% +$36.3K ﹤0.01% 1481
2025
Q2 		$4.27M Sell
566,781
-8,750
-2% -$70.3K ﹤0.01% 1309
2025
Q1 		$4.36M Sell
575,531
-4,605
-0.8% -$44.2K ﹤0.01% 1314
2024
Q4 		$7.07M Buy
580,136
+19,263
+3% +$277K ﹤0.01% 1165
2024
Q3 		$9.39M Buy
560,873
+5,806
+1% +$103K ﹤0.01% 1031
2024
Q2 		$9.68M Buy
555,067
+5,791
+1% +$123K ﹤0.01% 1018
2024
Q1 		$9.36M Buy
549,276
+3,692
+0.7% +$57K ﹤0.01% 1047
2023
Q4 		$5.56M Buy
545,584
+540,967
+11,717% +$4.79M ﹤0.01% 1208
2023
Q3 		$41.8K Sell
4,617
-3,676
-44% -$38.3K ﹤0.01% 3438
2023
Q2 		$89.2K Sell
8,293
-7,670
-48% -$81.5K ﹤0.01% 3321
2023
Q1 		$163K Buy
15,963
+3,654
+30% +$40.3K ﹤0.01% 3102
2022
Q4 		$130K Buy
12,309
+204
+2% +$2.48K ﹤0.01% 3203
2022
Q3 		$155K Sell
12,105
-1,993
-14% -$26.9K ﹤0.01% 3087
2022
Q2 		$181K Sell
14,098
-264
-2% -$2.99K ﹤0.01% 3232
2022
Q1 		$150K Sell
14,362
-1,662
-10% -$22.5K ﹤0.01% 3413
2021
Q4 		$247K Buy
16,024
+822
+5% +$16.4K ﹤0.01% 3273
2021
Q3 		$343K Buy
15,202
+6,882
+83% +$184K ﹤0.01% 3268
2021
Q2 		$214K Sell
8,320
-262
-3% -$8.06K ﹤0.01% 3747
2021
Q1 		$358K Buy
+8,582
New +$348K ﹤0.01% 3312

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Deutsche Bank's CGEM Position: Q2 2026 in Review

Deutsche Bank increased its Cullinan Oncology (CGEM) stake by 4.1% in Q2 2026, buying an estimated $222K and bringing the position to 382,840 shares worth $6.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Deutsche Bank first reported a position in CGEM in Q1 2021 and has held it in 22 quarters since. The position peaked at $9.68M in Q2 2024. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Deutsche Bank held 382,840 shares of Cullinan Oncology worth $6.97M as of Q2 2026.
  • Deutsche Bank bought 14,934 Cullinan Oncology shares in Q2 2026, an estimated $222K.
  • Cullinan Oncology made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1198 holding.
  • Deutsche Bank first reported a position in Cullinan Oncology in Q1 2021 and has held it in 22 quarters since.
  • Deutsche Bank's Cullinan Oncology position peaked at $9.68M in Q2 2024.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.